Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Acute Reversible Cardiomyopathy Complicating Toxic Shock Syndrome

Acute Reversible Cardiomyopathy Complicating Toxic Shock Syndrome Abstract A case of severe left ventricular dysfunction and low cardiac output accompanying the toxic shock syndrome was documented by two-dimensional echocardiography and hemodynamic measurements. This dysfunction was reversible over a five-month period. This appears to be a well-documented case of cardiomyopathy and toxic shock syndrome. Back to top Article Information Reprint requests to Department of Cardiology, Geisinger Medical Center, Danville, PA 17822 (Dr Menapace). References 1. Todd J, Fishaut M, Kapral F, et al: Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet. 1978;2:1116-1118. PubMedGoogle ScholarCrossref 2. David JP, Chesney PJ, Wand PJ, et al: Toxic-shock syndrome: Epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med. 1980;303:1429-1435. PubMedGoogle ScholarCrossref 3. Shands KN, Schmid GP, Dan BB, et al: Toxic-shock syndrome in menstruating women: Association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med. 1980;303:1436-1442. PubMedGoogle ScholarCrossref 4. Toxic-Shock Syndrome—United States, 1970-1980, Centers for Disease Control. MMWR. 1981;30:25-28, 33.Google Scholar 5. McKenna UG, Meadows JA III, Brewer NS, et al: Toxic shock syndrome, a newly recognized disease entity: Report of 11 cases. Mayo Clin Proc. 1980;55:663-672. PubMedGoogle Scholar 6. Collier RJ, Pappenheimer AM Jr: Studies on the mode of action of diphtheria toxin: I. Phosphorylated intermediates in normal and intoxicated HeLa cells. J Exp Med. 1964;120:1007-1018. PubMedGoogle ScholarCrossref 7. Schlievert PM, Schoettle DJ, Watson DW: Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin. Infect Immun. 1979;23:609-617. PubMedGoogle ScholarCrossref 8. Schlievert PM: Purification and characterization of staphylococcal pyrogenic exotoxin type B , in Abstracts of the Annual Meeting of the American Society of Microbiology.. Washington, DC, American Society of Microbiology, 1980, No. B4.Google Scholar 9. Fisher RF, Goodpasture HC, Peterie JD, et al: Toxic shock syndrome in menstruating women. Ann Intern Med. 1981;94:156-163.Google ScholarCrossref 10. Rogolsky M: Nonenteric toxins of Staphylococcus aureus. Microbiol Rev. 1979;43:320-360. PubMedGoogle Scholar 11. Abdul-Karim FW, Lederman MM, Carter JR, et al: Toxic shock syndrome: Clinicopathologic findings in a fatal case. Hum Pathol. 1981;12:16-22. PubMedGoogle ScholarCrossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

Acute Reversible Cardiomyopathy Complicating Toxic Shock Syndrome

Loading next page...
 
/lp/american-medical-association/acute-reversible-cardiomyopathy-complicating-toxic-shock-syndrome-f2BiNq5xoD
Publisher
American Medical Association
Copyright
Copyright © 1982 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinte.1982.00340180190031
Publisher site
See Article on Publisher Site

Abstract

Abstract A case of severe left ventricular dysfunction and low cardiac output accompanying the toxic shock syndrome was documented by two-dimensional echocardiography and hemodynamic measurements. This dysfunction was reversible over a five-month period. This appears to be a well-documented case of cardiomyopathy and toxic shock syndrome. Back to top Article Information Reprint requests to Department of Cardiology, Geisinger Medical Center, Danville, PA 17822 (Dr Menapace). References 1. Todd J, Fishaut M, Kapral F, et al: Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet. 1978;2:1116-1118. PubMedGoogle ScholarCrossref 2. David JP, Chesney PJ, Wand PJ, et al: Toxic-shock syndrome: Epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med. 1980;303:1429-1435. PubMedGoogle ScholarCrossref 3. Shands KN, Schmid GP, Dan BB, et al: Toxic-shock syndrome in menstruating women: Association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med. 1980;303:1436-1442. PubMedGoogle ScholarCrossref 4. Toxic-Shock Syndrome—United States, 1970-1980, Centers for Disease Control. MMWR. 1981;30:25-28, 33.Google Scholar 5. McKenna UG, Meadows JA III, Brewer NS, et al: Toxic shock syndrome, a newly recognized disease entity: Report of 11 cases. Mayo Clin Proc. 1980;55:663-672. PubMedGoogle Scholar 6. Collier RJ, Pappenheimer AM Jr: Studies on the mode of action of diphtheria toxin: I. Phosphorylated intermediates in normal and intoxicated HeLa cells. J Exp Med. 1964;120:1007-1018. PubMedGoogle ScholarCrossref 7. Schlievert PM, Schoettle DJ, Watson DW: Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin. Infect Immun. 1979;23:609-617. PubMedGoogle ScholarCrossref 8. Schlievert PM: Purification and characterization of staphylococcal pyrogenic exotoxin type B , in Abstracts of the Annual Meeting of the American Society of Microbiology.. Washington, DC, American Society of Microbiology, 1980, No. B4.Google Scholar 9. Fisher RF, Goodpasture HC, Peterie JD, et al: Toxic shock syndrome in menstruating women. Ann Intern Med. 1981;94:156-163.Google ScholarCrossref 10. Rogolsky M: Nonenteric toxins of Staphylococcus aureus. Microbiol Rev. 1979;43:320-360. PubMedGoogle Scholar 11. Abdul-Karim FW, Lederman MM, Carter JR, et al: Toxic shock syndrome: Clinicopathologic findings in a fatal case. Hum Pathol. 1981;12:16-22. PubMedGoogle ScholarCrossref

Journal

Archives of Internal MedicineAmerican Medical Association

Published: May 1, 1982

Keywords: cardiomyopathy,toxic shock syndrome,ventricular dysfunction, left,hemodynamic measurements,low cardiac output,two-dimensional echocardiography

References